Cargando…

An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors

In the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Huiding, Li, Yupeng, Yu, Fang, Xie, Xiaoguang, Qiu, Kaixiong, Fu, Jijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661884/
https://www.ncbi.nlm.nih.gov/pubmed/26580609
http://dx.doi.org/10.3390/ijms161126026
_version_ 1782403067831910400
author Xie, Huiding
Li, Yupeng
Yu, Fang
Xie, Xiaoguang
Qiu, Kaixiong
Fu, Jijun
author_facet Xie, Huiding
Li, Yupeng
Yu, Fang
Xie, Xiaoguang
Qiu, Kaixiong
Fu, Jijun
author_sort Xie, Huiding
collection PubMed
description In the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and binding free energy (ΔG(bind)) calculation were performed in this work. Molecular docking was carried out to identify the key residues in the binding site, and MD simulations were performed to determine the detail binding mode. The results obtained from MD simulation reveal that the binding site is stable during the MD simulations, and some hydrogen bonds (H-bonds) in MD simulations are different from H-bonds in the docking mode. Based on the obtained MD trajectories, ΔG(bind) was computed by using Molecular Mechanics Generalized Born Surface Area (MM-GBSA), and the obtained energies are consistent with the activities. An energetic analysis reveals that both electrostatic and van der Waals contributions are important to ΔG(bind), and the unfavorable polar solvation contribution results in the instability of the inhibitor with the lowest activity. These results are expected to understand the binding between B-Raf and imidazopyridines and provide some useful information to design potential B-Raf inhibitors.
format Online
Article
Text
id pubmed-4661884
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-46618842015-12-10 An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors Xie, Huiding Li, Yupeng Yu, Fang Xie, Xiaoguang Qiu, Kaixiong Fu, Jijun Int J Mol Sci Article In the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and binding free energy (ΔG(bind)) calculation were performed in this work. Molecular docking was carried out to identify the key residues in the binding site, and MD simulations were performed to determine the detail binding mode. The results obtained from MD simulation reveal that the binding site is stable during the MD simulations, and some hydrogen bonds (H-bonds) in MD simulations are different from H-bonds in the docking mode. Based on the obtained MD trajectories, ΔG(bind) was computed by using Molecular Mechanics Generalized Born Surface Area (MM-GBSA), and the obtained energies are consistent with the activities. An energetic analysis reveals that both electrostatic and van der Waals contributions are important to ΔG(bind), and the unfavorable polar solvation contribution results in the instability of the inhibitor with the lowest activity. These results are expected to understand the binding between B-Raf and imidazopyridines and provide some useful information to design potential B-Raf inhibitors. MDPI 2015-11-16 /pmc/articles/PMC4661884/ /pubmed/26580609 http://dx.doi.org/10.3390/ijms161126026 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xie, Huiding
Li, Yupeng
Yu, Fang
Xie, Xiaoguang
Qiu, Kaixiong
Fu, Jijun
An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
title An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
title_full An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
title_fullStr An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
title_full_unstemmed An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
title_short An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
title_sort investigation of molecular docking and molecular dynamic simulation on imidazopyridines as b-raf kinase inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661884/
https://www.ncbi.nlm.nih.gov/pubmed/26580609
http://dx.doi.org/10.3390/ijms161126026
work_keys_str_mv AT xiehuiding aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT liyupeng aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT yufang aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT xiexiaoguang aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT qiukaixiong aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT fujijun aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT xiehuiding investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT liyupeng investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT yufang investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT xiexiaoguang investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT qiukaixiong investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT fujijun investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors